OICR11029 | OICR11029 : Inhibitor of BCL6
RATINGS:
Cellular Use: (0 reviews)

In Model Organisms: (0 reviews)
Vendors

Probe Summary

Targets Biochemical/Biophysical Potency Cellular Potency
BCL6
  • Kd:10 nM
  • IC50:375 nM
  • IC50:215 nM
up to 1 uM

Selectivity

In Vitro Selectivity Assessment
Potency Assay Off-Target:
Selective against other BTB domains: BAZF (BCL6B) 1.40 uM, FAZF, PLZF, Miz1, Kaiso, LRF > 10 uM. Ou ...

Potency
Cellular
In Vitro

BCL6

Mode of Action: Inhibitor

Structure-Activity-Relationship data available? Yes

DOI Reference: 10.1021/acsmedchemlett.2c00502

In Vivo Validations

Mouse
Dose: 1 mg/Kg IV, 10 mg/Kg PO
Route of delivery: Intravenous, Oral
Plasma half life: 3 h
Systemic clearance: 12 mL/min/Kg
Cmax: 4 uM
Bioavailability: 30%
Volume of Distribution at Steady-State: 0.4 L/Kg

DOI Reference: 10.1021/acsmedchemlett.2c00502

Negative Control Compounds

OICR11600
Notes: IC50 41.1 uM SPR, not active in cellular assays

Chemical Information

Molecular Formula C26H25Cl2N7O5
SMILEs C[C@H]1COCCN1c1cc(NC(=O)Cn2cc(-c3cc(Cl)c(O)c(C(N)=O)c3)c3c(=O)n(C)cnc32)c(Cl)cn1
InChI InChI=1S/C26H25Cl2N7O5/c1-13-11-40-4-3-35(13)20-7-19(18(28)8-30-20)32-21(36)10-34-9-16(22-25(34)31-12-33(2)26(22)39)14-5-15(24(29)38)23(37)17(27)6-14/h5-9,12-13,37H,3-4,10-11H2,1-2H3,(H2,29,38)(H,30,32,36)/t13-/m0/s1
Molecular weight 585.13 Da
AlogP 2.772100000000001
HBond acceptors 12
HBond donors 4
Atoms 65

Expert Reviews


No SERP comments found for OICR11029

Probe OICR11029 is in the process of SERP review.

Please continue to check back for new reviews and commentary.

If you would like to explore AI-generated evaluations, you may wish to visit the page for this compound on our collaborator website